Stocks

Amid a wave of consolidation, the Ottawa firm says the deal will give it a top-2 position in the Canadian adult-use weed market

As Canadian cannabis companies await US federal reform, Ottawa's Hexo creates a new American subsidiary to jump into the lucrative stateside market early

With a massive $164.7M Q3 loss and a second round of cuts, the Edmonton producer is illustrative of troubles in the Canadian cannabis industry

After posting a net income of US$30.1M in Q1, the Florida weed firm's merger with Harvest will test its industry-leading efficiency

With only 8% of the major US pot stock being held by institutional investors, the firm posted revenue of US$194.4 in Q1

Australis Capital CSO Jason Dyck explains how each type of cannabis is a distinct set of compounds and how zebrafish are contributing to pain research

In the final quarter before merging with Aphria, Tilray shows fiscal weakness

After posting an industry-leading US$260M in Q1, the American weed giant eyes domination in NY, NJ and internationally

While medical cannabis is excluded from the pharmaceutical supply chain, the deal sets a precedent for other health care institutions to follow suit

Pure Sunfarms will double capacity by 2022, despite oversupply issues and fierce competition in the Canadian pot market

With revenue of US$1.2B in 2021, Trulieve says the combined company will rival Curaleaf as America's biggest legal weed seller

With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture

Calgary-based producer will get 86 Spiritleaf pot shops that Inner Spirit owns and franchises

But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market

The major US weed firm adds its 13th state and strong footing in the first adult-use market set to launch in the South

Since receiving $221M from British American Tobacco, the Canadian cannabis firm has reported declining revenue

The Canadian cannabis retailer plans to expand to the US market this year after reporting revenue of $128.1M in fiscal 2020

Court ruling means US weed operators will continue to pay higher taxes than federally legal businesses

After 28K votes from Canadian cannabis consumers were cast, GTEC's premium BC brand rose to the top of 96 entrants

After its stock jumped 66%, MindMed now rivals Compass Pathways as the world's most valuable psychedelic company

Canadian weed titan inks deal with Southern Glazer's to sell its Quatreau CBD drinks across America

Although the Canadian company leads across several categories and jurisdictions, it's battling against price compression and packaging costs to win

Ontario producer's Good Farm likely wasn't even covering labour costs amid nationwide supply gluts, says BCMI Cannabis Report

'They should not have gotten a damn raise last year,' he says of his former colleagues in an in-depth interview

Innovative firsts like listing terpene content on product labels is the result of keeping a close ear to the ground floor of the market

With Democrats in complete control of US Congress, it could be a new era for reform and American pot stock opportunity

The mega-producer's valuation rose almost 70% on the day but is still a far-cry from where many bought in

John Arbuthnot says cannabis companies through this cycle will start to trade at multiples of revenue, earnings and EBITDA more so than we've ever seen

A company that reported Trulieve mislead investors is being sued for libel

Canopy stock jumped almost 16 per cent on the third-quarter earnings report

Massive bonuses and mansions drew the ire of shareholders in MedMen, which demoted its CEO on Friday

It may have been a sobering year for the legal weed industry, but cannabis still made major waves in society, politics and science in 2019

The company issued $15.5 million in bonds to fund the acquisition of cannabis properties

Shares of Curaleaf jump on its positive third quarter report

The Florida-based weed retailer continued its dominance in the Sunshine State posting a sparkling US$60 million net income

Around 100 kilograms of small-producer product will be the company's first major test in retail

Cannabis companies have a bad reputation when it comes to shady corporate governance, but oversight is about to get tighter

Innovative Industrial Properties is showing its sale-leaseback business model is a potent one

An analyst at investment bank Cantor Fitzgerald initiates coverage on six Canadian weed stocks with a bullish outlook on the sector based on improving sales and the pending launch of Cannabis 2.0

Sundial told investors it produced high-quality consistent cannabis while omitting how a customer was returning an alleged 554 kilograms of mouldy weed